Market cap
₹839 Cr
Revenue (TTM)
₹109 Cr
P/E Ratio
47.3
P/B Ratio
5.1
Div. Yield
0 %
Quality Score
7/10
Growth Score
7/10
Valuation Score
3/10
Momentum Score
5/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹18 Cr
-
ROE
17.3 %
-
ROCE
19.5 %
-
Industry P/E
44.98
-
EV/EBITDA
22.5
-
Debt to Equity
0.1
-
Book Value
₹126.9
-
EPS
₹13.8
-
Face value
10
-
Shares outstanding
12,837,620
10 Years Aggregate
CFO
₹93.40 Cr
EBITDA
₹168.47 Cr
Net Profit
₹114.63 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Shree Remedies
| 41.1 | 26.0 | 26.0 | 6.1 | 31.6 | 19.1 | -- |
|
BSE Healthcare
| 9.3 | 8.9 | 9.3 | 11.7 | 26.8 | 14.1 | 12.2 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Shree Remedies
| -29.6 | -6.5 | 179.1 | -21.9 | 132.2 | 137.7 | 43.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Shree Remedies
|
653.8 | 839.3 | 109.3 | 17.8 | 22.5 | 11.2 | 47.3 | 5.1 |
| 2,923.8 | 23,906.4 | 1,339.4 | 356.4 | 33.2 | 23.2 | 67.1 | 14.5 | |
| 434.9 | 16,634.0 | 2,268.6 | 150.1 | 10.6 | 5.4 | 92.8 | 4.3 | |
| 758.4 | 18,786.7 | 5,365.6 | 595.0 | 16.6 | 13.3 | 31.6 | 3.7 | |
| 1,007.3 | 16,041.2 | 8,279.6 | 397.8 | 9.9 | 6.4 | 40.3 | 2.3 | |
| 1,173.0 | 21,006.0 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 13.5 | 2.4 | |
| 1,806.8 | 20,742.9 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.6 | |
| 179.5 | 23,840.1 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.9 | |
| 462.4 | 18,673.7 | 3,738.7 | 316.7 | 12.5 | 7.5 | 59 | 3.9 | |
| 1,637.6 | 26,638.2 | 3,373.0 | 199.0 | 12.6 | 5.9 | 125.1 | 5.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Shree Remedies
--
-
Incorporated
1995
-
Chairman
Chandulal Manubhai Kothia
-
Managing Director
Chandulal Manubhai Kothia
-
Headquarters
Ankleshwar, Gujarat
-
Website
Looking for more details about Shree Ganesh Remedies Ltd.’s IPO? Explore our IPO Details page.
Quarterly Updates
Annual Reports
FAQs for Shree Remedies
What is the current share price of Shree Ganesh Remedies Ltd Today?
The share price of Shree Ganesh Remedies Ltd is ₹653.75 (BSE) as of 25-May-2026 IST. Shree Ganesh Remedies Ltd has given a return of 31.61% in the last 3 years.
What is the current PB & PE ratio of Shree Ganesh Remedies Ltd?
The P/E ratio of Shree Ganesh Remedies Ltd is 47.26 times as on 25-May-2026, a 5 premium to its peers’ median range of 44.98 times.
The P/B ratio of Shree Ganesh Remedies Ltd is 5.15 times as on 25-May-2026, a 34 premium to its peers’ median range of 3.85 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
39.58
|
6.29
|
|
2024
|
30.49
|
7.02
|
|
2023
|
20.56
|
3.58
|
|
2022
|
26.39
|
5.78
|
|
2021
|
28.43
|
6.70
|
What is the 52 Week High and Low of Shree Ganesh Remedies Ltd?
The 52-week high and low of Shree Ganesh Remedies Ltd are Rs 658.00 and Rs 381.10 as of 25-May-2026.
What is the market cap of Shree Ganesh Remedies Ltd?
Shree Ganesh Remedies Ltd has a market capitalisation of ₹ 839 Cr as on 25-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Shree Ganesh Remedies Ltd?
Before investing in Shree Ganesh Remedies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.